George Church

Right now, we have miraculous things like cures for rare diseases.

We have vaccines.

We have a trillion dollars, probably, of various biotech-related things, if you go far enough apart.

but we're kind of on the verge of really combining electronics and biology more thoroughly and AI and biotech.

And I think that's, it seems like we're on the same track as Moore's law, if not better.

Well, 2040, we're talking about only 15 years, which is like one and a half, maybe two cycles of FDA approval.

2040 is post-AGI.

It's a long time.

Well, I hope it's not post-AGI.

I think we're rushing a little bit to get to AGI, and there's lots of cool things we can do with just super AI.

But we need to be very cautious, I think, that AGI.

Well, anyway, we could get into that.

But I think that we are shortening the time of getting medical products approved still in a safe way.

But that's not going to completely change the exponential.

It might reduce it from 10 years down to one year is our record so far for, say, COVID vaccines.

So maybe that'll be 10 times shorter.

Maybe that will multiply out a little bit.

But I think the big thing is that all our designs will become better, so there'll be fewer failures.

The cost per drug will drop.

There'll be things that we didn't classically consider drugs or instruments, some sort of hybrid thing.